The invention generally relates to methods of making substituted arenes via direct C—H amination. More specifically, methods of making para- and ortho-substituted arenes via direct C—H amination are disclosed. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

The invention generally relates to methods of making substituted arenes via direct C—H amination. More specifically, methods of making para- and ortho-substituted arenes via direct C—H amination are disclosed. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

The present invention comprises novel aromatic molecules, which can be used in the treatment of pathological conditions, such as cancer, skin diseases, muscle disorders, and immune system-related disorders such as disorders of the haematopoietic system including the haematologic system in human and veterinary medicine.

##STR00001##

The present invention comprises novel aromatic molecules, which can be used in the treatment of pathological conditions, such as cancer, skin diseases, muscle disorders, and immune system-related disorders such as disorders of the haematopoietic system including the haematologic system in human and veterinary medicine.

##STR00001##

The present invention relates to a plasticizer composition and a resin composition including the same. The compositions comprise a terephthalate-based material, a dibenzoate-based material, and a citrate. The compositions and methods have a weight ratio of the terephthalate-based material to the benzoate-based material of 99:1 to 1:99. The citrate-based material is included at 1 to 80 parts by weight with respect to 100 parts by weight of the total weight of the terephthalate-based material and the dibenzoate-based material.

The present invention relates to a plasticizer composition and a resin composition including the same. The compositions comprise a terephthalate-based material, a dibenzoate-based material, and a citrate. The compositions and methods have a weight ratio of the terephthalate-based material to the benzoate-based material of 99:1 to 1:99. The citrate-based material is included at 1 to 80 parts by weight with respect to 100 parts by weight of the total weight of the terephthalate-based material and the dibenzoate-based material.

Provided are a novel compound exhibiting the effect of treating, preventing or ameliorating lymphedema, and a composition including the same as an active ingredient, and may be applied as a medicament product, functional food or food supplement, or cosmetics. The compound used as an active ingredient compound according to the disclosure exhibits a remarkable ameliorating effect on lymphedema in various aspects such as TNFα production inhibitory activity, metabolic stability, solubility, and blood exposure.

Provided are a novel compound exhibiting the effect of treating, preventing or ameliorating lymphedema, and a composition including the same as an active ingredient, and may be applied as a medicament product, functional food or food supplement, or cosmetics. The compound used as an active ingredient compound according to the disclosure exhibits a remarkable ameliorating effect on lymphedema in various aspects such as TNFα production inhibitory activity, metabolic stability, solubility, and blood exposure.

Novel reaction media for electron donating and electron accepting components in colour-change compositions are described. The compound is of formula (VI); R.sub.1, and R.sub.2 are independently selected from an optionally substituted linear or branched alkyl group, alkenyl group, alkoxy group, aryl group and an alkylene aryl group having from 5 to 22 carbon atoms; X.sub.1 and X.sub.2 are independently selected from —OC(O)—, —CO.sub.2— and O; Y.sub.1, and Y.sub.2 are independently selected from hydrogen, halogen, R.sub.1, —OR.sub.1; y is independently 0 or 1; and suitably the groups R.sub.1X.sub.1— and —X.sub.2R.sub.2 are independently in the ortho or meta position. The compounds are useful in ink compositions, writing implements containing the compound and medical and industrial applications in which temperature sensitive colour change may be required. ##STR00001##

Novel reaction media for electron donating and electron accepting components in colour-change compositions are described. The compound is of formula (VI); R.sub.1, and R.sub.2 are independently selected from an optionally substituted linear or branched alkyl group, alkenyl group, alkoxy group, aryl group and an alkylene aryl group having from 5 to 22 carbon atoms; X.sub.1 and X.sub.2 are independently selected from —OC(O)—, —CO.sub.2— and O; Y.sub.1, and Y.sub.2 are independently selected from hydrogen, halogen, R.sub.1, —OR.sub.1; y is independently 0 or 1; and suitably the groups R.sub.1X.sub.1— and —X.sub.2R.sub.2 are independently in the ortho or meta position. The compounds are useful in ink compositions, writing implements containing the compound and medical and industrial applications in which temperature sensitive colour change may be required. ##STR00001##